PRLD
Price
$3.67
Change
-$0.12 (-3.17%)
Updated
Oct 2, 04:59 PM (EDT)
Capitalization
312.03M
34 days until earnings call
Intraday BUY SELL Signals
SRPT
Price
$17.50
Change
-$0.07 (-0.40%)
Updated
Oct 2 closing price
Capitalization
1.99B
33 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

PRLD vs SRPT

PRLD vs SRPT Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
PRLD vs. SRPT commentary
Oct 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PRLD is a Hold and SRPT is a StrongBuy.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS RATINGS
PRLD vs SRPT: Fundamental Ratings
PRLD
SRPT
OUTLOOK RATING
1..100
6067
VALUATION
overvalued / fair valued / undervalued
1..100
36
Fair valued
82
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10093
PRICE GROWTH RATING
1..100
4473
P/E GROWTH RATING
1..100
8668
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PRLD's Valuation (36) in the null industry is somewhat better than the same rating for SRPT (82) in the Biotechnology industry. This means that PRLD’s stock grew somewhat faster than SRPT’s over the last 12 months.

PRLD's Profit vs Risk Rating (100) in the null industry is in the same range as SRPT (100) in the Biotechnology industry. This means that PRLD’s stock grew similarly to SRPT’s over the last 12 months.

SRPT's SMR Rating (93) in the Biotechnology industry is in the same range as PRLD (100) in the null industry. This means that SRPT’s stock grew similarly to PRLD’s over the last 12 months.

PRLD's Price Growth Rating (44) in the null industry is in the same range as SRPT (73) in the Biotechnology industry. This means that PRLD’s stock grew similarly to SRPT’s over the last 12 months.

SRPT's P/E Growth Rating (68) in the Biotechnology industry is in the same range as PRLD (86) in the null industry. This means that SRPT’s stock grew similarly to PRLD’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
PRLDSRPT
RSI
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
69%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
78%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 2 days ago
75%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
78%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
78%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
76%
Advances
ODDS (%)
Bullish Trend 4 days ago
88%
Bullish Trend 5 days ago
77%
Declines
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
81%
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
74%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
75%
COMPARISON
Comparison
Oct 03, 2026
Stock price -- (PRLD: $3.79 vs. SRPT: $17.57)
Brand notoriety: PRLD: Not notable vs. SRPT: Notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PRLD: 93% vs. SRPT: 103%
Market capitalization -- PRLD: $312.03M vs. SRPT: $1.99B
PRLD [@Biotechnology] is valued at $312.03M. SRPT’s [@Biotechnology] market capitalization is $1.99B. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $133.74B. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PRLD’s FA Score shows that 0 FA rating(s) are green while SRPT’s FA Score has 0 green FA rating(s).

  • PRLD’s FA Score: 0 green, 5 red.
  • SRPT’s FA Score: 0 green, 5 red.
According to our system of comparison, PRLD is a better buy in the long-term than SRPT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PRLD’s TA Score shows that 3 TA indicator(s) are bullish while SRPT’s TA Score has 3 bullish TA indicator(s).

  • PRLD’s TA Score: 3 bullish, 6 bearish.
  • SRPT’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, both PRLD and SRPT are a bad buy in the short-term.

Price Growth

PRLD (@Biotechnology) experienced а -5.01% price change this week, while SRPT (@Biotechnology) price change was -4.46% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.63%. For the same industry, the average monthly price growth was -14.35%, and the average quarterly price growth was -1.64%.

Reported Earning Dates

PRLD is expected to report earnings on Nov 05, 2026.

SRPT is expected to report earnings on Nov 04, 2026.

Industries' Descriptions

@Biotechnology (-3.63% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
PRLD
Daily Signal:
Gain/Loss:
SRPT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
NANC52.610.11
+0.21%
Subversive Congressional Democrats Trading ETF (NANC)
NYM24.110.04
+0.17%
AB New York Intermediate Municipal ETF (NYM)
IWMY17.10-0.06
-0.35%
Defiance R2000 Weekly Distribution ETF (IWMY)
JANI25.28-0.17
-0.68%
AllianzIM International Equity Buffer15 Uncapped Jan ETF (JANI)
BTRN27.13-0.32
-1.18%
Global X Bitcoin Trend Strategy ETF (BTRN)

PRLD and

Correlation & Price change

A.I.dvisor indicates that over the last year, PRLD has been loosely correlated with SRPT. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if PRLD jumps, then SRPT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRLD
1D Price
Change %
PRLD100%
-3.07%
SRPT - PRLD
38%
Loosely correlated
-3.57%
VSTM - PRLD
36%
Loosely correlated
-1.86%
MLTX - PRLD
35%
Loosely correlated
-1.97%
NAUT - PRLD
35%
Loosely correlated
+10.56%
IMNM - PRLD
35%
Loosely correlated
-2.88%
More